| Clonal history and genetic predictors of transformation into small-cell carcinomas from lung adenocarcinomas JK Lee, J Lee, S Kim, S Kim, J Youk, S Park, Y An, B Keam, DW Kim, ... Journal of clinical oncology 35 (26), 3065-3074, 2017 | 425 | 2017 |
| Pan-cancer immunogenomic perspective on the tumor microenvironment based on PD-L1 and CD8 T-cell infiltration CY Ock, B Keam, S Kim, JS Lee, M Kim, TM Kim, YK Jeon, DW Kim, ... Clinical cancer research 22 (9), 2261-2270, 2016 | 256 | 2016 |
| Tumor-associated macrophages enhance tumor hypoxia and aerobic glycolysis H Jeong, S Kim, BJ Hong, CJ Lee, YE Kim, S Bok, JM Oh, SH Gwak, ... Cancer research 79 (4), 795-806, 2019 | 252 | 2019 |
| Clinicopathological analysis of PD-L1 and PD-L2 expression in pulmonary squamous cell carcinoma: Comparison with tumor-infiltrating T cells and the status of oncogenic drivers MY Kim, J Koh, S Kim, H Go, YK Jeon, DH Chung Lung cancer 88 (1), 24-33, 2015 | 225 | 2015 |
| Tracing oncogene rearrangements in the mutational history of lung adenocarcinoma JJK Lee, S Park, H Park, S Kim, J Lee, J Lee, J Youk, K Yi, Y An, IK Park, ... Cell 177 (7), 1842-1857. e21, 2019 | 195 | 2019 |
| Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: comparison of sarcomatous and carcinomatous areas S Kim, MY Kim, J Koh, H Go, DS Lee, YK Jeon, DH Chung European journal of cancer 51 (17), 2698-2707, 2015 | 189 | 2015 |
| Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomas D Kwon, S Kim, PJ Kim, H Go, SJ Nam, JH Paik, YA Kim, TM Kim, DS Heo, ... Histopathology 68 (7), 1079-1089, 2016 | 172 | 2016 |
| PD-L1 expression is associated with epithelial-to-mesenchymal transition in adenocarcinoma of the lung S Kim, J Koh, MY Kim, D Kwon, H Go, YA Kim, YK Jeon, DH Chung Human pathology 58, 7-14, 2016 | 157 | 2016 |
| PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma CY Ock, S Kim, B Keam, M Kim, TM Kim, JH Kim, YK Jeon, JS Lee, ... Oncotarget 7 (13), 15901, 2016 | 156 | 2016 |
| EML4-ALK enhances programmed cell death-ligand 1 expression in pulmonary adenocarcinoma via hypoxia-inducible factor (HIF)-1α and STAT3 J Koh, JY Jang, B Keam, S Kim, MY Kim, H Go, TM Kim, DW Kim, CW Kim, ... Oncoimmunology 5 (3), e1108514, 2016 | 143 | 2016 |
| Comparative analysis of PD-L1 expression between primary and metastatic pulmonary adenocarcinomas S Kim, J Koh, D Kwon, B Keam, H Go, YA Kim, YK Jeon, DH Chung European Journal of Cancer 75, 141-149, 2017 | 115 | 2017 |
| Prognostic implications of intratumoral CD103+ tumor-infiltrating lymphocytes in pulmonary squamous cell carcinoma J Koh, S Kim, MY Kim, H Go, YK Jeon, DH Chung Oncotarget 8 (8), 13762, 2017 | 91 | 2017 |
| Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma CY Ock, S Kim, B Keam, S Kim, YO Ahn, EJ Chung, JH Kim, TM Kim, ... Oncotarget 8 (58), 97920, 2017 | 87 | 2017 |
| Chemoradiation-induced alteration of programmed death-ligand 1 and CD8+ tumor-infiltrating lymphocytes identified patients with poor prognosis in rectal cancer: a matched … YJ Lim, J Koh, S Kim, SR Jeon, EK Chie, K Kim, GH Kang, SW Han, ... International Journal of Radiation Oncology* Biology* Physics 99 (5), 1216-1224, 2017 | 85 | 2017 |
| Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors R Kim, B Keam, S Kim, M Kim, SH Kim, JW Kim, YJ Kim, TM Kim, YK Jeon, ... BMC cancer 19, 1-10, 2019 | 82 | 2019 |
| Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to T-cell effector gene expression in non-small-cell lung cancer S Kim, JY Jang, J Koh, D Kwon, YA Kim, JC Paeng, CY Ock, B Keam, ... Journal of Experimental & Clinical Cancer Research 38, 1-14, 2019 | 54 | 2019 |
| Prognostic implications of CD30 expression in extranodal natural killer/T-cell lymphoma according to treatment modalities WY Kim, SJ Nam, S Kim, TM Kim, DS Heo, CW Kim, YK Jeon Leukemia & lymphoma 56 (6), 1778-1786, 2015 | 54 | 2015 |
| Effects of B7-H3 expression on tumour-infiltrating immune cells and clinicopathological characteristics in non–small-cell lung cancer J Yim, J Koh, S Kim, SG Song, HK Ahn, YA Kim, YK Jeon, DH Chung European Journal of Cancer 133, 74-85, 2020 | 53 | 2020 |
| Overexpression of endoplasmic reticulum stress-related proteins, XBP1s and GRP78, predicts poor prognosis in pulmonary adenocarcinoma D Kwon, J Koh, S Kim, H Go, HS Min, YA Kim, DK Kim, YK Jeon, ... Lung cancer 122, 131-137, 2018 | 53 | 2018 |
| Comparative analysis of the tumor immune-microenvironment of primary and brain metastases of non-small-cell lung cancer reveals organ-specific and EGFR mutation-dependent … SG Song, S Kim, J Koh, J Yim, B Han, YA Kim, YK Jeon, DH Chung Cancer Immunology, Immunotherapy 70, 2035-2048, 2021 | 51 | 2021 |
